Showing results (11-20 of 90) with videos related to
Sort By:
Pageof 9
Journal of Pharmaceutical Sciences|June 24, 2025
Using PEGylated antigen-expressing extracellular vesicles to accomplish splenic B cell-targeted antigen delivery for induction of antibodies against SARS-CoV-2 spike proteinSherif E Emam, Nehal E Elsadek, Haruka Takata, et al.The Journal of Gene Medicine|October 10, 2013
Polycation liposomes as a vector for potential intracellular delivery of microRNAHidenori Ando, Ayaka Okamoto, Masafumi Yokota, et al.Biological & Pharmaceutical Bulletin|September 2, 2016
Hydrodynamic Tail Vein Injection as a Simple Tool for Yielding Extended Transgene Expression in Solid TumorsTakuma Takayama, Masami Ukawa, Yuki Kanazawa, et al.Journal of Pharmaceutical Sciences|February 1, 2025
A spleen-targeted vaccine for SARS-CoV-2 - Inducting neutralizing antibodies in miceTaro Shimizu, Shunji Abe, Yoshino Kawaguchi, et al.Oncology Reports|September 14, 2022
Wnt2b and Wnt5a expression is highly associated with M2 TAMs in non‑small cell lung cancerRyota Sumitomo, Cheng-Long Huang, Hidenori Ando, et al.International Journal of Pharmaceutics|May 8, 2012
Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micellesHiroyuki Koide, Tomohiro Asai, Hiroki Kato, et al.Journal of Clinical Medicine|January 23, 2016
Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood FlowAyaka Okamoto, Tomohiro Asai, Sho Ryu, et al.Biochemical and Biophysical Research Communications|May 24, 2014
Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGFAyaka Okamoto, Tomohiro Asai, Hiroki Kato, et al.Immunobiology|June 23, 2015
Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cellsTaro Shimizu, Yu Mima, Yosuke Hashimoto, et al.The Journal of Gene Medicine|December 15, 2012
Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapyHidenori Ando, Ayaka Okamoto, Masafumi Yokota, et al.Pageof 9